 |
 |
|
|
RESÚMENES JULIO 2006 |
Addictive Disorders
(Haga un click en la
información del journal para acceder al resúmen)
Methadone Treatment in Clinical Practice in Italy: Need for Improvement
Patrizia Schifano, Anna Maria Bargagli, Valeria Belleudi, Laura
Amato, Marina Davoli,
Roberto Diecidue, Elisabetta
Versino, Federica Vigna-Taglianti, Fabrizio Faggiano, Carlo A. Perucci, for the
VEdeTTE Study Group
European Addiction
Research 2006;12:121-127
Naltrexone Implants - Duration, Tolerability and
Clinical Usefulness. A Pilot Study
Helge Waal, Grethe
Frogopsahl, Linda Olsen, Asbjørg
S. Christophersen, Jørg Mørland
European
Addiction Research 2006;12:138-144
Genetic and Environmental Influences on
Stages of Alcohol Use Across Adolescence and into
Young Adulthood
Jason L. Pagan, Richard J. Rose, Richard
J. Viken, Lea Pulkkinen,
Jaakko Kaprio and Danielle M. Dick
Behavior
Genetics 2006;
Volume 36, Number 4: 483 - 497
Relationship between
Adolescent Marijuana Use and Young Adult Illicit Drug Use
Jeffrey M. Lessem, Christian J. Hopfer,
Brett C. Haberstick, David Timberlake,
Marissa A. Ehringer, Andrew Smolen and John K. Hewitt
Behavior
Genetics 2006;
Volume 36, Number 4: 498 - 506
Genetic and Environmental
Vulnerabilities Underlying Adolescent Substance Use and Problem Use: General or
Specific?
Susan E. Young,
Soo Hyun Rhee, Michael C. Stallings,
Robin P. Corley and John K. Hewitt
Behavior
Genetics 2006;
Volume 36, Number 4: 603 - 615
Multimodal
drug addiction treatment: A field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients
Pierluigi Vigezzi, Livia Guglielmino, Paolo
Marzorati, Rosella Silenzio, Margherita De Chiara, Filomena Corrado, Laura
Cocchi and Edoardo Cozzolino
Journal of Substance Abuse Treatment. Volume 31, Issue 1, July 2006, Pages 3-7
Gene Variants of Brain Dopamine Pathways and
Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens
Arthur L. Brody, Mark A. Mandelkern,
Richard E. Olmstead, David Scheibal, Emily Hahn,
Sharon Shiraga, Eleanor Zamora-Paja,
Judah Farahi, Sanjaya Saxena, Edythe D. London, James T. McCracken
Arch Gen Psychiatry. 2006;63:808-816
Varenicline, an alpha-4-beta-2
Nicotinic Acetylcholine Receptor Partial Agonist, vs Sustained-Release
Bupropion and Placebo for Smoking Cessation. A Randomized
Controlled Trial
David Gonzales, Stephen I. Rennard,
Mitchell Nides, Cheryl Oncken,
Salomon Azoulay, Clare B. Billing, Eric J. Watsky, Jason Gong, Kathryn E. Williams, Karen R. Reeves,
for the Varenicline Phase 3 Study Group
Efficacy of Varenicline,
an alpha-4-beta-2 Nicotinic Acetylcholine Receptor Partial Agonist, vs Placebo or Sustained-Release Bupropion
for Smoking Cessation. A Randomized Controlled Trial
Douglas E. Jorenby, J.
Taylor Hays, Nancy A. Rigotti, Salomon Azoulay, Eric J. Watsky, Kathryn
E. Williams, Clare B. Billing, Jason Gong, Karen R. Reeves, for the Varenicline Phase 3 Study Group
Effect of Maintenance Therapy With
Varenicline on Smoking Cessation. A Randomized
Controlled Trial
Serena Tonstad, Philip Tønnesen, Peter Hajek, Kathryn E.
Williams, Clare B. Billing, Karen R. Reeves, for the Varenicline
Phase 3 Study Group
Bupropion for the treatment of nicotine withdrawal
and craving
Marc E Mooney and Mehmet Sofuoglu
Expert Review of Neurotherapeutics. July 2006, Vol. 6, No. 7, Pages 965-981
Pharmacotherapy of Alcoholism in
Patients with Co-morbid Psychiatric Disorders
Authors: Goldstein,
Benjamin I.; Diamantouros,
Artemis; Schaffer, Ayal; Naranjo, Claudio A.
Drugs, Volume 66, Number 9,
2006, pp. 1229-1237(9)
Potentiation of Low Dose Ketamine Effects
by Naltrexone: Potential Implications for the
Pharmacotherapy of Alcoholism
John H Krystal, Steven Madonick,
Edward Perry, Ralitza Gueorguieva,
Laura Brush, Yola Wray, Aysenil Belger and Deepak Cyril D'Souza
Neuropsychopharmacology (2006) 31, 1793–1800
Effects of Baclofen on Cocaine Self-Administration: Opioid- and Nonopioid-Dependent
Volunteers
Margaret Haney, Carl L Hart and Richard W Foltin
Neuropsychopharmacology (2006) 31, 1814–1821
Prevalence, Correlates, and Comorbidity of Nonmedical Prescription
Drug Use and Drug Use Disorders in the
Boji Huang, Deborah A. Dawson,
Frederick S. Stinson, Deborah S. Hasin, W. June Ruan, Tulshi D. Saha, Sharon M. Smith, Risë B.
Goldstein, and Bridget F. Grant
J Clin Psychiatry 2006;67:1062-1073
Baseline predictors of serious adverse
events at one year among patients with bipolar disorder in STEP-BD
Martinez JM, Marangell LB, Simon NM, et al.
Alcohol consumption as a risk factor for
anxiety and depression—results from the longitudinal follow-up of the National
Psychiatric Morbidity Survey
Haynes
JC, Farrell M, Singleton N, et al.
Br J Psychiatry 2005;187:544–51
One-Year
Follow-Up Study of Suicide Attempters Treated for Drug Dependence
Vito Agosti and Frances R. Levin
American Journal on
Addictions. Volume 15, Number 4 / July-August 2006: 293 - 296
Switching between
Methadone and Morphine for Maintenance Treatment of Opioid
Dependence: Impact on Pain Sensitivity and Mood Status
Timothy
B. Mitchell, Jason M. White, Andrew A. Somogyi, Felix
Bochner
American Journal on
Addictions. Volume 15, Number 4 / July-August 2006: 311 - 315
Predictors of Long-Term Benzodiazepine
Abstinence in Participants of a Randomized Controlled Benzodiazepine Withdrawal
Program